Article ; Online: Perception of pharmacological equivalence of generics or biosimilars in healthcare professionals in Vienna.
European journal of clinical pharmacology
2023 Volume 80, Issue 3, Page(s) 355–366
Abstract: Purpose: Due to constantly rising therapy costs, biosimilars and generic drugs have gained tremendous importance through recent decades. Nevertheless, the acceptance among healthcare workers regarding biosimilars and generic drugs in previously ... ...
Abstract | Purpose: Due to constantly rising therapy costs, biosimilars and generic drugs have gained tremendous importance through recent decades. Nevertheless, the acceptance among healthcare workers regarding biosimilars and generic drugs in previously published international studies is considerably lower than the scientific data on equivalent safety and efficacy would suggest. The aim of this questionnaire-based survey was to determine the perception and knowledge regarding generic drugs and biosimilars by medical professionals from different healthcare facilities in Vienna, Austria. Methods: The online questionnaire was sent to public and religious hospitals in Vienna, including the university hospital "Vienna General Hospital." In addition, doctors' offices were reached by sending out the questionnaire in the weekly news of the Vienna Medical Association. Results: A total of 282 physicians and 311 graduated nurses took part in the study. 63% and 62% of the participants were convinced that generic respective biosimilar drugs were clinically equivalent to the original reference drug. On average, 1.6 out of 4 knowledge questions were answered correctly about generics, while only 0.87 out of 4 questions were answered accurately about biosimilars. Conclusion: The results of this study support the outcome from previous surveys demonstrating that a large proportion of healthcare professionals is still skeptical about generics and biosimilars. According to the results of this study, better education of the medical staff might ensure greater acceptance of these types of drugs. |
---|---|
MeSH term(s) | Humans ; Biosimilar Pharmaceuticals/therapeutic use ; Drugs, Generic/therapeutic use ; Health Personnel ; Attitude of Health Personnel ; Perception |
Chemical Substances | Biosimilar Pharmaceuticals ; Drugs, Generic |
Language | English |
Publishing date | 2023-12-22 |
Publishing country | Germany |
Document type | Journal Article |
ZDB-ID | 121960-1 |
ISSN | 1432-1041 ; 0031-6970 |
ISSN (online) | 1432-1041 |
ISSN | 0031-6970 |
DOI | 10.1007/s00228-023-03603-3 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 672: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.